UNSPSC 51401560: Adinazolam mesilate or mesylate

This classification denotes a benzodiazepine with the molecular formula C19H18CLN5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NT8S62A727. The term adinazolam mesilate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule adinazolam mesylate under HS 29339940. As of Q4 2014, ADINAZOLAM MESYLATE remains US FDA's Preferred Term for this commodity. Adinazolam mesylate bears US NLM identifiers UMLS ID C0167214 and NCI Concept Code C76532.

SMILES: CN(C)CC1NNC2N1-C3CCC(CC3C(=NC2)C4CCCCC4)CL.CS(=O)(=O)O.

UNSPSC 51401560 Adinazolam mesilate or mesylate is a Commodity code that nominally describes a specific benzodiazepine pharmaceutical, but recent state and local procurement activity under the code shows a mismatch with this nominal scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—addresses opioid harm reduction and public health response rather than adinazolam procurement. The county is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their proposal, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract runs for an initial two-year term with a one-year renewal option and includes a three-month probationary period during which the county may terminate with or without cause.

The code shows minimal relevant recent activity. Seminole County, a county-level health department buyer in Florida, is the only issuing body reflected in recent opportunities. The IFB (Solicitation Number IFB60459723LAS) was posted on June 30, 2026, with a response deadline of July 26, 2023—a date in the past relative to the posting. The procurement indicates potential FEMA funding, which introduces compliance requirements under the Clean Air Act and Federal Water Pollution Control Act, with contractors subject to audits and record inspections. The mismatch between the code's nominal pharmaceutical scope and the naloxone-and-systems procurement activity suggests either a tagging error in the opportunity database or that this Commodity code does not reflect current state and local buying patterns in this category.